Fusion Antibodies plc (LON:FAB – Get Free Report)’s share price was down 6.8% during trading on Tuesday . The company traded as low as GBX 7.23 ($0.09) and last traded at GBX 7.50 ($0.10). Approximately 1,222,605 shares were traded during trading, a decline of 10% from the average daily volume of 1,362,271 shares. The stock had previously closed at GBX 8.05 ($0.10).
Fusion Antibodies Price Performance
The company has a debt-to-equity ratio of 2.40, a quick ratio of 2.36 and a current ratio of 3.87. The company has a fifty day moving average price of GBX 8.38 and a two-hundred day moving average price of GBX 5.93. The company has a market cap of £6.56 million, a P/E ratio of -1.57 and a beta of 0.49.
Fusion Antibodies Company Profile
The Company’s ordinary shares were admitted to trading on AIM on 18 December 2017. Fusion provides a broad range of services in antibody generation, development, production, characterisation and optimisation.
Further Reading
- Five stocks we like better than Fusion Antibodies
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Top Biotech Stocks: Exploring Innovation Opportunities
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- Bank Stocks – Best Bank Stocks to Invest In
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for Fusion Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fusion Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.